We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$76.1B
AUM Growth
+$4.53B
(+6.3%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
798
New
67
Increased
286
Reduced
299
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$550M |
| 2 |
Goldman Sachs
GS
|
+$448M |
| 3 |
ConocoPhillips
COP
|
+$390M |
| 4 |
BorgWarner
BWA
|
+$373M |
| 5 |
Marathon Petroleum
MPC
|
+$365M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$545M |
| 2 |
Occidental Petroleum
OXY
|
+$491M |
| 3 |
Verizon
VZ
|
+$433M |
| 4 |
RTN
Raytheon Company
RTN
|
+$266M |
| 5 |
Aon
AON
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.05% |
| 2 | Healthcare | 13.47% |
| 3 | Technology | 12.73% |
| 4 | Energy | 10.48% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Chemed
CHE
$6.78B
| $51M | 0.07% |
317,631
-1,093
| -0.3% | -$161K |
|
227
Bruker
BRKR
$9.2B
| $50.2M | 0.07% |
2,371,061
+193,290
| +9% | +$4.23M |
|
228
First American
FAF
$7.67B
| $48M | 0.06% |
1,309,359
+7,635
| +0.6% | +$293K |
|
229
Assured Guaranty
AGO
$3.78B
| $47.9M | 0.06% |
1,269,434
+3,910
| +0.3% | +$131K |
|
230
Lockheed Martin
LMT
$134B
| $47.3M | 0.06% |
189,373
-834,260
| -81% | -$208M |
|
231
Alibaba
BABA
$269B
| $46.3M | 0.06% |
526,720
+604
| +0.1% | +$58.2K |
|
232
Avery Dennison
AVY
$12.3B
| $46.1M | 0.06% |
656,714
+53,583
| +9% | +$3.89M |
|
|
CYS
233
DELISTED
CYS Investments Inc.
CYS
| $45.9M | 0.06% |
5,943,918
+15,170
| +0.3% | +$124K |
|
|
MYCC
234
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $45.6M | 0.06% |
3,179,925
+25,707
| +0.8% | +$342K |
|
235
FirstEnergy
FE
$28.9B
| $45.1M | 0.06% |
1,456,140
+119,267
| +9% | +$3.82M |
|
236
Belden
BDC
$4B
| $44.5M | 0.06% |
595,679
+5,053
| +0.9% | +$360K |
|
237
Nomad Foods
NOMD
$1.64B
| $43.9M | 0.06% |
4,582,146
+840,934
| +22% | +$9.18M |
|
238
Tetra Tech
TTEK
$8.23B
| $43.4M | 0.06% |
5,025,675
-3,370
| -0.1% | -$27.2K |
|
|
ODP
239
DELISTED
ODP
ODP
| $42.9M | 0.06% |
949,881
+3,609
| +0.4% | +$149K |
|
|
MDRX
240
DELISTED
Veradigm Inc. Common Stock
MDRX
| $42.4M | 0.06% |
4,150,060
+2,369,215
| +133% | +$27M |
|
|
PRXL
241
DELISTED
Parexel International Corp
PRXL
| $42.3M | 0.06% |
643,608
-409
| -0.1% | -$25.6K |
|
242
Altria Group
MO
$122B
| $40.2M | 0.05% |
+594,004
| New | +$38.3M |
|
|
FCB
243
DELISTED
FCB Financial Holdings, Inc.
FCB
| $39.3M | 0.05% |
824,357
-52,074
| -6% | -$2.16M |
|
244
Minerals Technologies
MTX
$2.31B
| $39.2M | 0.05% |
507,275
-3,150
| -0.6% | -$234K |
|
245
Danaher
DHR
$135B
| $38.8M | 0.05% |
562,535
+236
| +0% | +$16.4K |
|
|
COHR
246
DELISTED
Coherent Inc
COHR
| $38.8M | 0.05% |
282,375
-1,299
| -0.5% | -$158K |
|
247
Lithia Motors
LAD
$7.78B
| $38.8M | 0.05% |
400,282
-1,812
| -0.5% | -$166K |
|
|
MFA
248
MFA Financial
MFA
$929M
| $38.7M | 0.05% |
1,269,296
+1,897
| +0.1% | +$57K |
|
249
TTEC Holdings
TTEC
$103M
| $38.7M | 0.05% |
1,267,756
-6,471
| -0.5% | -$186K |
|
|
SKX
250
DELISTED
Skechers
SKX
| $38.5M | 0.05% |
1,565,664
+699,319
| +81% | +$16.1M |
|
Similar funds
Boston Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Boston Partners held 798 positions worth $76.1B, up 6.3% from $71.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q4 2016 filing shows 67 new, 286 increased, 299 reduced and 53 closed positions. Its largest new stake was BorgWarner: 11,568,722 shares worth $402M. The largest sale was McKesson, an estimated $545M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q4 2016 buy was BorgWarner: 11,568,722 shares worth $402M.
- Boston Partners added most to Pfizer in Q4 2016, an estimated $550M increase.
- Boston Partners's biggest Q4 2016 reduction was McKesson, cutting an estimated $545M.
- Boston Partners fully exited Valspar in Q4 2016, selling an estimated $177M.
- Boston Partners's ten largest holdings make up 17% of its $76.1B portfolio in Q4 2016.
- Boston Partners opened 67 new positions and closed 53 in Q4 2016.
- Boston Partners's portfolio value rose 6.3% quarter-over-quarter to $76.1B.
Based on Boston Partners's 13F filing for Q4 2016, filed 6 Feb 2017.